Harrow Stock

Harrow Enterprise Value

The Enterprise Value (EV) of Harrow (HROW) as of Aug 6, 2026 is 1.45 B USD. In the previous year, Enterprise Value (EV) was 1.45 B USD — a change of -0.14% (lower).

Enterprise Value

1.45 BUSD

YoY

-0.14%

Last updated:

Enterprise Value (EV) of Harrow is 2026 1.45 B USD. Enterprise Value (EV) of Harrow was 2025 1.45 B USD. It decreases by -0.14% lower compared to the previous year.
Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

Enterprise Value (EV) of Harrow is 1.45 B USD in 2026.

Enterprise Value (EV) of Harrow changed from 1.45 B USD to 1.45 B USD, representing a -0.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Harrow since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Harrow with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Harrow

All Key Metrics — Harrow